Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes - PubMed (original) (raw)
. 1988 Jun 5;263(16):7760-6.
Affiliations
- PMID: 3131326
Free article
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes
L T May et al. J Biol Chem. 1988.
Free article
Abstract
The cDNA for human beta 2-interferon (IFN-beta 2)/B-cell differentiation factor 2/hepatocyte-stimulating factor was expressed in Escherichia coli to yield a fusion protein which contains the 182 carboxyl-terminal amino acids of IFN-beta 2 fused to a 34-amino acid prokaryotic leader peptide (rIFN-beta 2). When added to cultures of human hepatoma cell line Hep3B2, rIFN-beta 2 as well as preparations of natural IFN-beta 2 enhance secretion of positive acute phase reactants such as alpha 1-antichymotrypsin, complement C3, fibrinogen, and alpha 1-acid glycoprotein and inhibit secretion of albumin, confirming that a protein derived from the IFN-beta 2 gene can have hepatocyte-stimulating factor activity. We have prepared a rabbit polyclonal antiserum to the E. coli-derived human IFN-beta 2 fusion protein. This polyclonal antiserum inhibits the hepatocyte-stimulating and B-cell differentiation activities of appropriate IFN-beta 2 preparations. The anti-rIFN-beta 2 antiserum has been used in immunoprecipitation experiments and in Western blots to help define the secretory proteins derived from the IFN-beta 2 gene in fibroblasts and monocytes. "Uninduced" human FS-4 fibroblasts as well as those induced with interleukin-1 alpha, tumor necrosis factor, or bacterial lipopolysaccharide secrete at least five forms of IFN-beta 2 of apparent molecular mass in the range from 23 to 30 kDa which can be resolved by polyacrylamide gel electrophoresis under denaturing and reducing conditions. The three higher molecular mass forms are not observed when FS-4 cells are induced in the presence of tunicamycin, suggesting that these forms are N-glycosylated (gp28, gp29, and gp30). Although secretion of the two lower molecular mass forms is resistant to tunicamycin, they are labeled by [3H]glucosamine (gp23-gp25). The inclusion of cycloheximide during the [35S]methionine labeling of induced FS-4 cells results in the preferential synthesis and secretion of the 29-kDa triplet. Human monocytes induced with bacterial lipopolysaccharide also secrete several distinct forms of IFN-beta 2 in the size range from 23 to 30 kDa which co-migrate in polyacrylamide gels with those obtained from FS-4 cells. Our observations help relate previous descriptions of multiple forms of hepatocyte-stimulating factor to specific proteins derived from the IFN-beta 2 gene.
Similar articles
- Phosphorylation of secreted forms of human beta 2-interferon/hepatocyte stimulating factor/interleukin-6.
May LT, Santhanam U, Tatter SB, Bhardwaj N, Ghrayeb J, Sehgal PB. May LT, et al. Biochem Biophys Res Commun. 1988 May 16;152(3):1144-50. doi: 10.1016/s0006-291x(88)80404-2. Biochem Biophys Res Commun. 1988. PMID: 3259872 - Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factor/interleukin 6 gene in virus-infected human fibroblasts.
Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT. Sehgal PB, et al. J Exp Med. 1988 Jun 1;167(6):1951-6. doi: 10.1084/jem.167.6.1951. J Exp Med. 1988. PMID: 3133443 Free PMC article. - Cell-free-synthesized interleukin-6 (BSF-2/IFN-beta 2) exhibits hepatocyte-stimulating activity.
Geiger T, Andus T, Bauer J, Northoff H, Ganter U, Hirano T, Kishimoto T, Heinrich PC. Geiger T, et al. Eur J Biochem. 1988 Jul 15;175(1):181-6. doi: 10.1111/j.1432-1033.1988.tb14181.x. Eur J Biochem. 1988. PMID: 2456923 - Cooperation of liver cells in health and disease.
Kmieć Z. Kmieć Z. Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3. Adv Anat Embryol Cell Biol. 2001. PMID: 11729749 Review. - Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS, Selemon H, Elton SM, Parinandi NL. Elton TS, et al. Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Gene. 2013. PMID: 23246696 Review.
Cited by
- Interleukin-6 in psoriasis: expression and mitogenicity studies.
Elder JT, Sartor CI, Boman DK, Benrazavi S, Fisher GJ, Pittelkow MR. Elder JT, et al. Arch Dermatol Res. 1992;284(6):324-32. doi: 10.1007/BF00372034. Arch Dermatol Res. 1992. PMID: 1294020 - Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.
Neurath AR, Strick N, Li YY. Neurath AR, et al. J Exp Med. 1992 Dec 1;176(6):1561-9. doi: 10.1084/jem.176.6.1561. J Exp Med. 1992. PMID: 1334115 Free PMC article. - Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C.
Gross V, Zhang B, Geng Y, Villiger PM, Lotz M. Gross V, et al. J Clin Immunol. 1993 Sep;13(5):310-20. doi: 10.1007/BF00920239. J Clin Immunol. 1993. PMID: 8245177 - Production and modulation of interleukin 6 synthesis by synoviocytes derived from patients with arthritic disease.
Rosenbaum JT, Cugnini R, Tara DC, Hefeneider S, Ansel JC. Rosenbaum JT, et al. Ann Rheum Dis. 1992 Feb;51(2):198-202. doi: 10.1136/ard.51.2.198. Ann Rheum Dis. 1992. PMID: 1550404 Free PMC article. - Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells.
Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB. Tamm I, et al. J Exp Med. 1989 Nov 1;170(5):1649-69. doi: 10.1084/jem.170.5.1649. J Exp Med. 1989. PMID: 2553849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous